Research in Motion Ltd. (BBRY) A Takeover Target: Jim Cramer

BlackBerry Ltd (NASDAQ:BBRY)CNBC analyst and personality (with emphasis on personality) Jim Cramer is back at it again. In the wake of a Research in Motion Ltd. (NASDAQ:BBRY) earning report that far surpassed Wall Street estimates (an actual EPS of 22 cents compared ao 29-cent loss estimate), it appears that BlackBerry is back at the forefront of discussion among smartphone company investors. While the Z10 launched in the middle of the company’s quarter, it reported 1 million sales of the new flagship handset, the Z10, which runs the new BlackBerry 10 operating system.

Cramer spoke extensively about Research in Motion Ltd. (NASDAQ:BBRY) on Thursday’s “Squawk on the Street” program, saying that this latest earning report could be a catalyst for a takeover attempt by another tech company. On the one hand, Cramer said that the earnings could suggest that “they will be in business for a long time,” and may increase the likelihood that another company – he mentioned Nokia Corporation (ADR) (NYSE:NOK) or Microsoft Corporation (NASDAQ:MSFT) could make a play for the company.

“This company was supposed to have a terrible quarter. This was not a terrible quarter,” Cramer said of Research in Motion Ltd. (NASDAQ:BBRY). “This company was on the ropes. It’s not anymore.” Cramer made note that BlackBerry has a very loyal following in overseas markets, most notably Indonesia and Europe. “This is an entrenched product in some places, and it is very difficult to unseat a product that is so entrenched.

800px-Blackberry“There are a lot of things that can go right with BlackBerry if the balance sheet improves, which it has. Things can change quickly,” Cramer added.

What are your thoughts about Research in Motion Ltd. (NASDAQ:BBRY) in the wake of this latest earning report? Do you agree with Cramer’s assessment of this company? Is it on its way back? Give us your thoughts in the comments section below.

DISCLOSURE: I own no positions in any stock mentioned.

 

Please see these related BBRY articles:

So, Is BlackBerry 10 a Hit or Not?

Why BlackBerry and Lenovo are Heading into an Alliance

Don’t Pass Up This Tech Deal

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!